Keyphrases
Therapeutic Potential
100%
Airway
100%
Influenza-like Illness
100%
Chemical Agents
100%
Secretory Leukocyte Protease Inhibitor
100%
Pulmonary Surfactant
100%
Protease
83%
Influenza Virus
50%
Immunoglobulin
50%
Virus
33%
Viral Replication
16%
Human Influenza
16%
Survival Rate
16%
Trypsin
16%
Interleukin-12 (IL-12)
16%
Optimal Dose
16%
Mucosal Immunity
16%
Upper Respiratory Tract
16%
Viral Glycoprotein
16%
Intranasal Administration
16%
Infected Cells
16%
Adsorption
16%
Anti-influenza Agents
16%
Age of Infection
16%
Sendai Virus
16%
Protease Activity
16%
Clarithromycin
16%
Antioxidant Agents
16%
Ambroxol
16%
Infectious Pathogens
16%
Defensive Compounds
16%
Defensive Factor
16%
Immunity Level
16%
Lower Respiratory Tract
16%
Natural Inhibitors
16%
Inhibitory Compounds
16%
Virus Proliferation
16%
Mucosal Vaccine
16%
Human Parainfluenza Virus Type 1
16%
Lethal Dose
16%
Viral Membrane Fusion
16%
Sialyltransferase Inhibitors
16%
Macrolide Antibiotics
16%
Organ Tropism
16%
Mucolytics
16%
Viral Membrane Protein
16%
Recombinant Glycoprotein
16%
Medicine and Dentistry
Influenza A Virus
100%
Virus Infection
100%
Proteinase
100%
Pulmonary Surfactant
100%
Secretory Leukocyte Protease Inhibitor
100%
Immunoglobulin A
50%
Glycoprotein
33%
Virus Replication
16%
Survival Rate
16%
Pathogen
16%
Antioxidant
16%
Infection
16%
Optimal Drug Dose
16%
Precursor
16%
Sialidase Inhibitor
16%
Interleukin 12
16%
Human Parainfluenza Virus 1
16%
Membrane Fusion
16%
Sendai Virus
16%
Virus Envelope
16%
Mucolytic Agent
16%
Mucosal Immunity
16%
Upper Respiratory Tract
16%
Lower Respiratory Tract
16%
Ambroxol
16%
Clarithromycin
16%
Intranasal Drug Administration
16%
Macrolide
16%
Pharmacology, Toxicology and Pharmaceutical Science
Influenzavirus A
100%
Proteinase
100%
Virus Infection
100%
Pulmonary Surfactant
100%
Secretory Leukocyte Proteinase Inhibitor
100%
Immunoglobulin A
50%
Respiratory Tract
33%
Glycoprotein
33%
Antioxidant
16%
Survival Rate
16%
Infectious Agent
16%
Infection
16%
Sialidase Inhibitor
16%
Macrolide
16%
Clarithromycin
16%
Interleukin 12
16%
Human Parainfluenza Virus 1
16%
Mucolytic Agent
16%
Sendai Virus
16%
Ambroxol
16%
Immunology and Microbiology
Influenzavirus A
100%
Viral Disease
100%
Immunoglobulin A
60%
Glycoprotein
40%
Viral Replication
20%
Survival Rate
20%
Infectious Agent
20%
Precursor
20%
Mucosal Immunity
20%
Viral Envelope
20%
Influenza
20%
Liquid
20%
Sendai Virus
20%
Membrane Fusion
20%
Lower Respiratory Tract
20%
Upper Respiratory Tract
20%
Human Parainfluenza Virus 1
20%
Optimal Drug Dose
20%
Interleukin 12
20%